2009 panel discussions will focus on the science, business, policy, law and ethics of all stem cell types including human embryonic stem cells, adult stem cells and induced pluripotent stem cells.

To maximize the potential of stem cell research, the 2009 World Stem Cell Summit program is designed to cover the field’s most pressing topics including: progressive research strategies, translational and preclinical findings, cross disciplinary initiatives, drug discovery, funding opportunities (federal, public and private), commercialization plans, technology transfer platforms, venture capital insight, market trends, regulatory issues, ethical and societal implications, philanthropic opportunities, medical tourism challenges, cell banking projects, intellectual property landscapes, insurance questions, international perspectives, clinical use and the 2009-10 advocacy agenda.

The 2009 Summit will feature an advanced science track featuring some of the world's most prominent scientists addressing the latest discoveries in basic research, translational and preclinical findings, bioengineering and cellular scaffold initiatives, clinical trials updates, and an in depth look at the pharmaceutical industry's short term and long term vision for stem cells.

For the first time the Summit’s educational program will be jointly sponsored by University of Maryland School of Medicine for AMA_PRA Category 1 CreditTM.

Lastly, the 2009 Summit will feature several economic development panels designed to enhance states and nations economic strategies and opportunities for constructive collaborations.

2009 Registration Rates * Industry/For-Profit Early Discount Rate: $1095 - Deadline-July 30 ($1595 On and after July 31) * Government, Non-Profit, Academic Early Discount Rate: $695 - Deadline-July 30 ($795 On and after July 31) * Student Rate: $395 (Graduate Students, Undergraduate Students and Ph.D. Candidates)